MoleMapCD technology is recommended for patients at high-risk of melanoma, including:

Personal history of melanoma and at least one of the following:

• greater than one primary melanoma
• family history (1st or 2nd degree) of melanoma
• “dysplastic” nevi (any number)
• multiple nevi (> 10)
• high patient anxiety about possibility of other lesions of the skin surface being melanoma*

Family history of melanoma (1st or 2nd degree) and at least one of the following:

• at least one clinically “dysplastic” nevus
• multiple nevi (> 10)
• evidence or significant solar damage (multiple lentigines)

Multiple “dysplastic” nevi (> 4)

Multiple prior nevus biopsies (>4) due to concern of possible melanoma (not cosmetic)

Large congenital nevus

Note: Depending on your threshold for performing biopsies, total body photography leads to the increased detection of “de novo” melanomas in your high-risk patients.

*Some high-risk patients are particularly anxious about real or perceived changes in their skin, which can lead to unnecessary phone calls and office visits. Others have a difficult time performing self-examinations of their skin. Both groups of patients are excellent candidates for a MoleMapCD.

MoleMapCD technology is not intended as a replacement to visual exams conducted by physicians. It is an adjunct tool designed to facilitate physicians' ability to document changes in the skin.